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ABSTRACT 
 
Cancer is the second leading cause of death in the world and cancer-related fatigue (CRF) is the most common disease 
in cancer patients that received radiotherapy, chemotherapy, hormone therapy and biotherapy. Many studies 
recommended physical activity and exercise to improve fatigue. This systematic review aims to provide a qualitative 
synthesis of Randomized Clinical Trials (RCTs) evaluating the effects of Aerobic, Resistance, Endurance and 
combined exercises on CRF versus control or different exercise group in cancer adult patients and survivors that did 
not receive palliative care. This systematic review is written and presented according to PRISMA protocols. Articles in 
the English language were collected using the PubMed and WoS databases from 2001 January 1st to 2019 September 
1st. Only RCTs lasted 5 weeks or more were analysed of which CRF outcomes were examined. A total of 15 RCTs 
met our inclusion criteria. Different outcomes in CRF self-reports were found between Aerobic, Resistance, Endurance 
and Combined exercises. Findings suggest that exercise improves CRF, especially with aerobic or combined 
programs. The outcomes of trials could help exercise professionals to properly plan the sessions by dosing the volume 
and intensity. Nevertheless, more studies are needed to better understand the beneﬁts of physical exercise on cancer 
patients. Keywords: Aerobic; Resistance; Endurance; Combined exercise; Physical activity; Cancer. 
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INTRODUCTION 
 
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. If the 
spread is not controlled, it can result in death. It is the second leading cause of death in the world and its 
incidence is growing, with 21.7 million new yearly cases predicted worldwide by 2030 (Torre et al., 2015). 
Five states with the highest incidence are Denmark (338/100,000), France (325/100,000), Australia 
(323/100,000), the USA (318/100,000) and South Korea (308/100,000) (Kessels et al., 2018). For example, 
the American Cancer Society (2019) estimated 1,762,450 of new cases for cancer in USA and about 371,000 
in Italy during 2019 (AIOM, 2019). Cancer is caused by internal factors, such as inherited genetic mutations, 
hormones, and immune conditions and external factors, such as tobacco, infectious organisms, and an 
unhealthy diet; in 2012, USA registered about 5% of all cancers were caused by inactivity (Parkin et al., 
2011). Furthermore, Cancer was estimated to have resulted in 208.3 million disability-adjusted-life-years in 
2015 (Bernsten et al., 2017). One of these is cancer-related fatigue (CRF) (Akechi et al., 1999). 
 
CRF is defined by the National Comprehensive Cancer Network (NCCN, 2003) as “a persistent, subjective 
sense of tiredness related to cancer or cancer treatment that interferes with usual functioning”; 70–100% of 
patients being treated for cancer are affected by CRF, which can be more distressing and disruptive to daily 
activities than the pain associated with the disease (Curt et al., 2000). It is a common disease in patients who 
received radiotherapy, chemotherapy, hormone therapy and biotherapy (Jacobsen et al., 1999; Robinson & 
Posner, 1992; Sitzia & Huggins, 1998; Stone et al., 2000). CRF was added to ‘’International Classification of 
Disease’’ (Cella et al., 2001) and guidelines for its management were made (NCCN, 2003). Its effects may 
be incurred during treatments and they persist for many months or years (Bower et al., 2000; Broeckel et al., 
1998). The effects of CRF also have deleterious influences on patients’ and survivors’ physical, mental, and 
emotional well-being (Cataldi, Latino, Greco, & Fischetti, 2019; Hofman et al., 2007). Several factors have 
been identified in research as contributing to fatigue, but it is still unclear what is most influent (Ryan et al., 
2007). Physiological and psychosocial factors play a part in the specific mechanisms involved in the 
development of CRF (Ahlberg et al., 2003; Fischetti et al., 2019); an import contribute was made by muscular 
metabolism (Brown et al., 2005; Forsyth et al., 1999; Isaksson et al., 2002; Lane et al., 1998; Lee et al., 2003; 
McCully et al., 1996). For assessment and management of CRF, different scales and questionnaire were 
made (Cleeland et al., 1999; Mendoza et al., 1999; Piper, 1997; Piper et al., 1989; Piper et al., 1998; 
Schwartz, 1998; Schwart & Meek, 1999; Smets et al., 1995; Sutherland et al., 1999). 
 
The NCCN’s (2015) clinical practice guidelines recommend physical activity and exercise to improve fatigue, 
undergoing and/or after treatments. A recent meta-analysis showed that both exercise and psychological 
treatments have small effect sizes in CRF, whereas medication has no effects, with most effects of exercise 
during cancer therapy (Mustian et al., 2017). Despite the evidence of training’s benefits, cancer survivors or 
patients report a significant decline in exercise after diagnosis, with less than 50% engaging in a beneficial 
exercises program (Humpel & Iverson, 2007; Midtgaard et al., 2009). A Cochrane systematic review and 
meta-analysis by Cramp and Byron-Daniel (2012) examined the effects of exercises on CRF in patients who 
received palliative or non-palliative treatments. Another review of Kessels et al. (2018) exceeded this problem 
establishing the effects of exercises on CRF in a population not suffering from specific end-life-distress, but 
they used only MET to quantify the intensity of exercises. Also, we included RCT 3-armed. 
 
This study aims to provide a systematic review of RCTs evaluating the effects of Aerobic, Resistance, 
Endurance and combined exercises on CRF versus control or different exercise group, confronted from 
baseline to one or more follow-ups, in cancer patients and survivors who were adult (18 years old or more) 
and who did not receive palliative care. Different self-report used for fatigue outcomes and exercise intensity 
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was registered by common methods as percentage of HRmax (Cinke & Thomas, 1981) or HRr (Cheng et al., 
2002), RPE (Borg, 1970), METs (Mendes et al., 2018), 1RM (Delorme & Watkins, 1948) and VO2peak (Noonan 
& Dean, 2000). 
 
METHODS 
 
Search strategy and information processing 
The systematic review is written and presented according to PRISMA protocols (Liberati et al., 2009). 
PubMed (a search engine for free access to the MEDLINE database of citations and abstracts of biomedical 
research articles) and Web of Science (online scientiﬁc information service, provided by Thomson Reuters, 
integrated in ISI Web of Knowledge, WOK, containing original articles based on clinical trials) databases 
were used to obtained all the data used in this study. The keywords used were: (‘’cancer patients’’ OR ‘’cancer 
survivors’’) AND (‘’fatigue’’ OR ‘’cancer-related fatigue) AND ‘’exercise’’ AND ‘’randomized controlled trial’’ 
AND ‘’free full text’’ AND ‘’custom date range (‘’2001 January 1st to 2019 September 1st’’). The search string 
was (‘’cancer patients’’ [All Fields] OR ‘’cancer survivors [All Fields]) AND (‘’fatigue’’ [All Fields] OR ‘’cancer-
related fatigue’’ [All Fields]) AND ‘’exercise’’. There was a custom date range published from 2001 January 
1st to 2019 September 1st. 
 
Eligibility criteria 
Table 1. PICOST eligibility criteria. 
Parameter Inclusion criteria Exclusion criteria 
Patients 
Adults (>18 years) living with or 
beyond cancer diagnosis not 
receiving palliative care, 
undergoing or post therapy and/or 
treatment 
Patients <18 years 
Patients receiving palliative care 
Patients without cancer 
Patients with unrecoverable 
metastatic disease 
Intervention 
Physical activity with AE, RE, EN 
and/or combined exercises 
Yoga, Dance, Qigong, Powerlifting, 
Tai chi, Pilates, Mindfulness, 
Chess, Physiotherapy, Music 
therapy, CBT, EMS, Isometric 
training, Psychoeducation, Diet and 
Dietary supplements 
Comparator 
Non-exercise control group; RE, AE 
or EN exercise group 
Non-exercise control group 
receiving additional care, such as 
diet, CBT, physiotherapy, etc. 
Outcome 
Perceived of Fatigue measured by 
self-report questionnaire 
No fatigue result 
Study design  
RCTs with length of follow up of 5 
weeks or more  
Non-RCTs 
RCTs lasted 4 weeks or less 
No English language  
Timing 
From 2001 January 1st to 2019 
September 1st  
Before 2001 and after 2019 
September 1st  
Abbreviations: AE, Aerobic; RE, Resistance; EN, Endurance; CBT, Cognitive Behavioural Therapy; EMS, Electric Muscular 
Stimulation; RCTs, Randomized Controlled Trials. 
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A summary of the inclusion and exclusion criteria for this review is shown in PICOST (Miller, 2001) Table 1. 
Each of the identiﬁed articles was independently analysed by three researchers. Patients were adults (≥18 
years) living with, or beyond, any cancer diagnosis, undergoing or after some therapy and/or treatment; they 
didn’t receive palliative care but active treatment as surgery, radiotherapy (included ADT), chemotherapy 
and/or hormone therapy. Metastatic diseases were included if it was not unrecoverable. We included RCTs 
in which were Aerobic, Resistance, Endurance and/or combined exercise. We examined only RCT in which 
were CRF outcomes. Only Randomized Controlled Trials were analysed, which were published from 2001 
January 1st to 2019 September 1st. We considered acceptable RCT which lasted 5 weeks or more and had 
one or multiple follow-ups for inclusion. We considerable acceptable all intensity of exercise if it was correctly 
reported. We excluded Yoga, Qigong, Tai chi, Powerlifting, Pilates and Dance exercises because they need 
a specialist trainer and some of them request a good motor activity experience. Every study had at least one 
control group, who didn’t exercise, and could compare two or more group if it was a 3-armed trial. Outcomes 
had to underline changes in fatigue and were expressed in quantitative measures by a validated self-report 
questionnaire. Only English language was acceptable for inclusion study. 
 
Data collection process and analysis 
Two independent reviewers extracted data available in the full free texts. All variables for which data were 
sought are: a) Fatigue severity, measured by self-report questionnaire validated to assess and manage CRF 
in patients or survivors and expressed in p-value; b) Number of patients of interventions or control groups, 
sample mean age, gender of patients; c) Type of cancer and treatment; d) Type of exercise, its intensity and 
its frequency; e) Length of study analysis; f) Intervention in groups. 
 
The principal summary measures were expressed as standardizes difference in means (Cohen’s d) of CRF 
and p-value to quantify the idea of statistical significance of evidence. It is assumed that an effect size d ≥ 
.80 represents a large effect, .50 ≤ d < .80 medium and d < .50 small (Cohen, 1988). P-value is generally 
considered an α = .05 as a threshold value under which data has a statistical significance (Wasserstein & 
Lazar., 2016). 
 
Additional analyses 
We analysed 4 different interventions: 
1. Aerobic exercises as walking, jogging, swimming, biking and running. For stay in aerobic training, 
level of intensity was between 40-65% HRmax, 50-75% HRr, or 35-50% VO2peak. 
2. Resistance exercises as muscular contraction on machine or with resistance band. The intensity 
wasn’t over 85% 1RM. 
3. Endurance exercises that trained cardiovascular and respiratory system with high intensity (>80% 
HRr or 75%< VO2peak <95%) 
4. Combined two or more of precedent interventions. 
 
RESULTS 
 
Study selection 
The search strategy found 1880 RCTs, of which 827 were free full texts. After checking for duplicates, 
remained 651 RCTs. From these, 47 trials were included for independent screening. 32 trials were excluded 
and only 15 respected the inclusion criteria (reported in Table 1) and were included in the systematic review. 
The PRISMA flow diagram (Moher et al., 2009) reported in Figure 1 reports an overview of ‘’study selection’’. 
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Figure 1. Flowchart on the literature search of exercise effects on cancer-related fatigue. 
 
Study characteristics 
All 15 trials were RCTs (Adams et al., 2018; Cormie et al., 2015; Dieli-Conwright et al., 2018; Galiano-Castillo 
et al., 2016; Hojan et al., 2016; Hwang et al., 2008; Kampshoff et al., 2015; Monga et al., 2007; Paulo et al., 
2019; Penttinen et al., 2019; Pinto et al., 2005; Schmidt et al., 2015; Segal et al., 2009; Shobeiri et al., 2016; 
Steindorf et al., 2014). Table 2 reviews all patient details. In total, 1664 patients were included in the trials, of 
whom 376 were men and 1288 were women. 905 patients were randomized in an intervention group 
(IG1+IG2) and 749 were randomized in a control group of which 36 received a basic recommendation for 
exercise (Galiano-Castillo et al., 2016) and 142 followed relaxation treatment (Paulo et al., 2019; Schmidt et 
al., 2015; Steindorf et al., 2014). The weighted average age was 54.91. In 9 RCTs patients reported breast 
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Records excluded based on title 
and abstract (n = 604): 
No fatigue outcomes (n=257), 
Study protocol (n=45), 
No adults (n=3), 
Other treatments (n=163), 
No cancer patients (n=55), 
No CG (n=27), 
No IG (n=44), 
Palliative care (n=10). 
 
 
 
 
Full-text articles assessed for 
eligibility (n=47) 
Full-text articles excluded, 
with reasons (n=32): 
No exercises expressed (n=10), 
No CRF results (n=11), 
No data of patients expressed 
(n=3), 
Other interventions combined 
with exercises (n=8) 
Studies included in 
qualitative synthesis (n=15) 
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cancer (Dieli-Conwright et al., 2018; Galiano-Castillo et al., 2016; Hwang et al., 2008; Paulo et al., 2019; 
Penttinen et al., 2019; Pinto et al., 2005; Schmidt et al., 2015; Shobeiri et al., 2016; Steindorf et al., 2014), in 
4 reported prostate cancer (Cormie et al., 2015; Hojan et al., 2016; Monga et al., 2007; Segal et al., 2009), 
in 1 reported testicular cancer (Adams et al., 2018), in 1 multiple cancer (Kampshoff et al., 2015). In 8 trials 
patients were still undergoing different therapies (Cormie et al., 2015; Hojan et al., 2016; Hwang et al., 2008; 
Monga et al., 2007; Paulo et al., 2019; Schmidt et al., 2015; Segal et al., 2009; Steindorf et al., 2014), in 3 
trials patients completed therapies (Kampshoff et al., 2015; Penttinen et al., 2019; Shobeiri et al., 2016) and 
in 4 trials patients were analysed after therapies (Adams et al., 2018; Dieli-Conwright et al., 2018; Galiano-
Castillo et al., 2016; Pinto et al., 2005). Exercise interventions lasted from 5 weeks (Mendes et al., 2018) to 
5 years (Penttinen et al., 2019), of which 11 trials did follow-up at baseline and after treatment (Adams et al., 
2018; Cormie et al., 2015; Dieli-Conwright et al., 2018; Galiano-Castillo et al., 2016; Hojan et al., 2016; Hwang 
et al., 2008; Kampshoff et al., 2015; Pinto et al., 2005; Shobeiri et al., 2016; Schmidt et al., 2015), 3 RCTs 
did 3 different follow-up (baseline, T1 and T2) (Paulo et al., 2019; Segal et al., 2009; Steindorf et al., 2014) 
and other one trial did 6 follow-ups (Penttinen et al., 2019). 
 
Table 2. Patients details. 
Study Patients IG1 IG2 CG Age (yrs.) Gender 
Paulo et al. (2019) 36 18 0 18 65 female 
Shobeiri et al. (2016) 53 27 0 26 43 female 
Galiano-Castillo et al. (2016) 72 36 0 36 48 female 
Schmidt et al. (2015) 95 49 0 46 53 female 
Adams et al. (2018) 63 35 0 28 44 male 
Penttinen et al. (2019) 444 235 0 209 53 female 
Dieli-Conwright et al. (2018) 91 46 0 45 53 female 
Steindorf et al. (2014) 155 77 0 78 56 female 
Kampshoff et al. (2015) 277 91 95 91 54 f=223; m=54 
Hojan et al. (2016) 54 27 0 27 68.5 male 
Monga et al. (2007) 21 11 0 10 69 male 
Segal et al. (2009) 121 40 40 41 66 male 
Hwang et al. (2008) 37 17 0 20 46 female 
Cormie et al. (2015) 63 32 0 31 68.5 male 
Pinto et al. (2005) 82 39 0 43 53 female 
ALL 1664 780 135 749 54.91* f=1288; m=376 
*Weighted average of age; IG, intervention group; CG, control group; m, male; f, female. 
 
Results of individuals studies 
The results are summarized in Table 3. Thirteen RCTs found improvements in CRF (Adams et al., 2018; 
Cormie et al., 2015; Dieli-Conwright et al., 2018; Galiano-Castillo et al., 2016; Hojan et al., 2016; Hwang et 
al., 2008; Kampshoff et al., 2015; Monga et al., 2007; Paulo et al., 2019; Pinto et al., 2005; Segal et al., 2009; 
Shobeiri et al., 2016; Steindorf et al., 2014), one trial found improvements only in patients who were not 
affected of depression (Schmidt et al., 2015) and other one trial found improvements in patients who changed 
intensity of exercise or physical performance (Penttinen et al., 2019). Four types of exercise intervention 
were used: Aerobic (Monga et al., 2007; Pinto et al., 2005; Segal et al., 2009; Shobeiri et al., 2016); 
Resistance (Schmidt et al., 2015; Segal et al., 2009; Steindorf et al., 2014); Endurance (i.e., High Intensity 
Interval Training) (Adams et al., 2018), Combined (Cormie et al., 2015; Dieli-Conwright et al., 2018; Galiano-
Castillo et al., 2016; Hojan et al., 2016; Kampshoff et al., 2015; Mendes et al., 2018; Paulo et al., 2019; 
Penttinen et al., 2019). One of these trials (Segal et al., 2009) found improvements in CRF with aerobic 
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Table 3. Studies that investigated the eﬀects of exercise on cancer-related fatigue. 
Article -n IG1 
-n IG2 
-n CG 
-Age (sm) 
-Sex 
-Cancer 
-Treatment 
-Outcome instrument 
-P-Value 
-Exercise 
-Intensity 
-Frequency 
-Time follow-up 
-All Outcomes 
compared 
Activity IG Control Group 
RCT (2x3) Paulo et 
al. (2019)  
-n=18 
-n= 
-n=18 
-65 years 
-female 
-Breast (100%) 
-Undergoing 
aromatase 
inhibition therapy 
-EORTCQLQ-30 
-p<.001 (IG vs. CG) 
 
-AE+RE 
-60-85% HRmax (AE) 
-Max rep (RE) 
-3 d/w 
-9 Months 
-Improved: 
CRF, Nausea, 
Dyspnoea, Sleep 
disturbance, Physical 
fitness, etc. 
Warm-up + 40’ RE 
exercises on machine 
+ 30’ AE exercise + 
cool-down 
45’ of Stretch and relaxation 
exercise, 2 d/w 
RCT (2x2) Shobeiri 
et al. (2016)  
-n=27 
-n= 
-n=26 
-43 years 
-female 
-Breast (100%) 
-Completed 
surgery and RT o 
CT 
-EORTCQLQ-30 
-p<.001 (IG vs. CG) 
-AE 
-50-75% HRr 
-2 d/w 
-10 Weeks 
-Improved: CRF, 
Nausea, Pain, 
Dyspnoea, Insomnia, 
physical and mental 
fitness and QoL 
Warm-up (5-10’ of 
stretching and 
moderate walking) + 
15’ of AE exercise + 5’ 
of cool down 
Usual Care and sedentary 
lifestyle 
RCT (2X2) 
Galiano-Castillo et 
al. (2016)  
-n=36 
-n= 
-n=36 
-48 years 
-female 
-Breast (100%) 
-After RT and/or 
CT 
-PFS 
-p<.05 (IG vs CG) 
-AE+RE 
-ACSM guidelines 
-3 d/w 
-6 Months 
-Improved: CRF, 
Health status, 
Physical and 
Cognitive fitness 
90’ of training with 
warm-up + AE and RE 
exercises + cool down 
Basic recommendation for 
exercises 
RCT (2x2) Schmidt 
et al. (2015)  
-n=49 
-n= 
-n=46 
-53 years 
-female 
-Breast (100%) 
-Undergoing 
adjuvant CT 
-FAQ 
-p<.098 (patients with 
high lv of depression) 
-p<.038 (patients 
without depression) 
-RE 
-60-80% 1RM 
-2 d/w 
-12 Weeks 
-Improved: CRF, 
social and role f. 
8 machines based 
progressive RE 
training (3 sets x 12 
repetition); no AE 
exercises 
Relaxation accord to 
Jacobsen (Jacobsen & al., 
1999) 
RCT (2X2) Adams 
et al. (2018)  
-n=35 
-n= 
-n=28 
-44 years 
-male 
-Testicular 
(100%) 
-After RT, CT or 
others 
-FACT-F 
-p=.003 
-High Intensity 
Interval-Training 
-75-95% VO2max 
-3 d/w 
-3 Months 
-Improved: CRF, 
Mental component 
and vitality 
Warm-up 5’ + 
HIIT 25’ (4 sets x 4’, 3’ 
of active recovery in 3 
intervals) + cool down 
 
Maintained baseline exercise 
lv 
RCT * 
Penttinen et al. 
(2019)  
-n=235 
-n= 
-n=209 
-53 years 
-female 
-Breast (100%) 
-Completed CT 
and RT or 
started ET 
-FACIT-F 
-p=.065 (in patients 
without increment of 
MET-h/w) 
-AE + RE + EN 
-RPE 14-16 
-Incremented MET-
h/w or changed 
-5 Years 
-Improved: CRF, 
Physical and Role 
fitness 
1 day with 60’ of AE 
exercises and circuit 
training 
2 days (at least) of EN 
exercise 
Maintained baseline 
exercises lv 
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-p=.002 (in patients 
with increment of MET-
h/w) 
-p=.003 (patients who 
changed p. 
performance) 
physical 
performance 
-3 or more d/w 
 
RCT (2x2) Dieli-
Conwright et al. 
(2018)  
-n=46 
-n= 
-n=45 
-63 years 
-female 
-Breast (100%) 
-After CT e RT 
-BFI 
-p<.001 (IG vs CG) 
-AE + RE 
-65-80% HRmax 
-60-80% 1RM 
(weight increased by 
10-15%) 
-3 d/w 
-12 Weeks 
-Improved: CRF, 
Physical fitness, QoL 
Day 1 and 3: 5’ warm-
up + 70’ RE and AE 
exercises + 5’ cool 
down 
Day 2: 30-50’ of AE 
exercises 
Usual care 
RCT (2x3) 
Steindorf et al. 
(2014)  
-n=77 
-n= 
-n=78 
-56 years 
-female 
-Breast (100%) 
-Undergoing 
adjuvant RT 
-FAQ 
-p=.044 
-RE 
-60-80% 1RM 
-2 d/w 
-12 Weeks 
- Improved: CRF, 
Pain 
60’ with 8 different 
machine-based RE 
exercise (3 sets of 8-
12 reps) 
Relaxation without RE and 
AE exercises 
RCT (2x2) 
Hojan et al. (2016)  
-n=27 
-n= 
-n=27 
-68.5 years 
-male 
-Prostate (100%) 
-
Undergoing RT 
-FACT-F 
-p<.001 
-AE + RE 
-65-70% HRr 
-70-75% 1RM 
-5 d/w 
-3-5 Months 
-Improved: 
CRF, Physical fitness 
and Well-being 
5’ warm-up + 
30’ AE exercise + 15 
RE exercise + 5’ cool 
down 
Activity of daily 
living without physical 
exercises 
RCT 
(3X2) Kampshoff 
et al. (2015)  
-n=91 (HI) 
-n=95 (LMI) 
-n=91(WLC) 
-54 years 
-male (20%) 
-
female (80%) 
-Breast (65%), 
-Colon (17.7%), 
-Ovarian (4.3%), 
-Lymphoma 
(9.4%), 
-Cervix (1.7%) 
-Testis (1.9%) 
-
Completed CT 
-MFI 
-p<.05 (HI vs WLC) 
-p<.05 (LMI 
vs WLC) 
-RE + EN 
-HI 70-85% 1RM 
and ≥ 80% HRr 
-LMI 40-55% 1RM 
and 40-55% HRr 
 
-12 Weeks 
-Improved 
CRF (HI and LMI) 
and Physical f. (HI 
and LMI) 
6 RE exercises for LMI 
and HI (2 sets of 10 
rep) 
2x8’ at 
different workload for 
LMI and HI 
Wait list control  
RCT (2x2) 
Monga et al. (2007)  
-n=11 
-n= 
-n=10 
-69 years 
-male 
-Prostate (100%) 
-
Undergoing RT 
-PFS 
-p<.001 
-AE 
-Maintained target 
HR 
-2 or more 
d/w 
-8 Weeks 
-Improved: 
CRF, Physical 
performance and 
Well-being 
10’ warm-up 
+ 30’ AE (walking) + 5-
10’ cool down 
Usual care without 
exercises 
RCT (3x3) 
Segal et al. (2009)  
-n=40 (RE) 
-n=40 (AE) 
-Prostate (100%) -FACT-F -RE or AE 
-60-70% 1RM 
-12-24 Weeks 5’ warm-up + 
10 different exercises 
Usual care 
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-n=41 (CG) 
-66 years 
-male 
-
Undergoing RT 
-p<.004 (AE vs CG at 
first follow-up) 
-p<.002 (RE 
vs CG at last follow-up) 
-50-75% VO2max 
-3 d/w 
-Improved: 
CRF (AE vs CG at 
week 12; RE vs CG 
at week 24), etc. 
(2 sets of 8-12 rep) + 
15-45’ of AE exercises 
(cycle ergometer, 
treadmill or elliptical + 
5’ cool down 
RCT (2x2) 
Hwang et al. (2008)  
-n=17 
-n= 
-n=20 
-46 years 
-
female 
-Breast (100%) 
-
Undergoing RT 
-BFI 
-p<.05 
-AE+RE 
-50-70% HRmax 
-3 d/w 
-5 Weeks 
-Improved 
CRF, QoL, Pain, 
ROM 
10’ warm-up 
+ 30’ of AE and RE 
exercises 
Usual care 
RCT (2x2) 
Cormie et al. 
(2014)  
-n=32 
-n= 
-n=31 
-68.5 years 
-male 
 
-Prostate (100%) 
-
Undergoing ADT 
-FACIT-F 
-p=.042 
-AE+RE 
-70-85% HRmax 
-60-85% 1RM 
-2 d/w 
-3 Months 
-Improved 
CRF, Mental health, 
Sexual and Physical 
fitness, Body 
composition 
Warm-up + 
20-30’ of AE exercises 
+ 8 RE exercises (1-4 
sets of 6-12 rep) + cool 
down. Total of 60’. 
Usual care 
RCT (2x2) 
Pinto et al. (2005)  
-n=39 
-n= 
-n=43 
-53 years 
-
female 
-Breast (100%) 
-After 
RT, CT and/or 
HT 
-LASA 
-p=.001 
-AE 
-55-65% HRmax 
-2 to 5 d/w 
-12 Weeks 
-Improved: 
CRF and Physical 
activity 
10-30’ of AE 
exercises 
Maintained lv of 
daily activity 
*RCT including 3 study-arm and 6 follow-ups. Abbreviations: AE, Aerobic; RE, Resistance; CRF, Cancer Related Fatigue; RT, Radiotherapy; CT, Chemotherapy; HT, Hormone 
Therapy; ADT, Androgen Deprivation Therapy; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; FACIT-F, 
Functional Assessment of Chronic Illness Therapy- Fatigue Scale; BFI, Brief Fatigue Inventory; PFS, Piper Fatigue Scale; MFI, Multidimensional Fatigue Inventory; FAQ, Fatigue 
Assessment Questionnaire; LASA, Linear Analogue Self-Assessment; IG, Intervention Group; CG, Control Group; Sm, Simple mean; HI, High Intensity; LMI, Low-To-Moderate 
Intensity; WLC, Wait List Control; HIIT, High Intensity Interval Training; ACSM, American College of Sport Medicine.
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exercise at first follow-up and with resistance exercise at last follow-up. Intensity of the exercise varied from 
low (Galiano-Castillo et al., 2016; Hwang et al., 2008; Pinto et al., 2005; Shobeiri et al., 2016) to moderate 
(Cormie et al., 2015; Dieli-Conwright et al., 2018; Hojan et al., 2016; Monga et al., 2007; Segal et al., 2009; 
Paulo et al., 2019; Schmidt et al., 2015; Steindorf et al., 2014) to high (Adams et al., 2018) or changed during 
treatment (Kampshoff et al., 2015; Penttinen et al., 2019). The most important outcomes were shown in two 
Aerobic treatment trials (Monga et al., 2007; Shobeiri et al., 2016) and two Combined treatment trials (Dieli-
Conwright et al., 2018; Paulo et al., 2019). 
 
Outcomes of RCTs 
The outcomes of trials are represented in Figure 2. Two RCTs didn’t report Cohen’s d (Hwang et al., 2008; 
Penttinen et al., 2019). The two three-armed studies (Kampshoff et al., 2015; Penttinen & al., 2019) showed 
different p-value for every experimental group confronted to control group. The most important effect size 
was found in four trials (Dieli-Conwright et al., 2018; Monga et al., 2007; Paulo et al., 2019; Shobeiri et al., 
2016). 
 
 
Where Cohen’s d results 0 we haven’t found value in trial. *In this trial there were 2 different p-value: .03 for group who changed 
performance and .02 in group who incremented MET. **In this trial there were 2 different p-value and effect size: Low to Moderate 
Intensity reported p<.05 and d=.31; High Intensity reported p<.05 and d=.35. ***In this trial there where 2 different p-value and 
effect size: Resistance Training reported p=.002 and d=.35; Aerobic Training reported p=.080 and d=.24. Groups were analysed 
at 24 weeks follow-up versus Usual Care group. 
 
Figure 2. Effect size and p-value of trials. 
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DISCUSSION 
 
Summary of evidence 
This study aims to investigate the effect of exercise on CRF, how exercise was used during the last decade 
and which is the best exercise program in the cancer patient. The results reported in Table 3 and Figure 2 
recommend that aerobic exercise improves CRF better than other treatments, but it also provides good 
outcomes combined with resistance training. To get the best results, the better way is doing exercises at 
least two days/week, for eight or more weeks. The studies in which are reported best improvements followed 
a low to moderate intensity of exercises, showing the same effects in men and women. Thus, according to 
NCCN (2015) and the American College of Sports Medicine (2018), physical activity makes better the quality 
of life in cancer patients and improves psychological and physiological fitness. 
 
Implication 
The positive effects found after an exercise treatment underline the importance of daily activities in the 
patient’s life during cancer disease. The preventive intervention allows us to increase the wellbeing of cancer 
patients improving fatigue sensation and helping patients undergoing therapy to continue their activity of life. 
Furthermore, exercise programs can increase muscle strength, physical fitness, physical and psychological 
function, body composition and can positively impact biomarkers associated with cancer progression (Stout 
et al., 2017). Changes on CRF are associated with other factors as pain, insomnia, depression, anxiety, 
mood disturbance and physiological distress factors (Ahlberg et al., 2003). In a study of Fiuza-Luces et al. 
(2013), exercise training was considered as a ‘’poly-pills’’ for its multiple effects (Stefani et al., 2016) and Van 
Waart et al. (2015) showed the beneficial outcomes observed in patients with cancer. 
 
Limitations 
The main limitations of this systematic review are: 
• A small number of trials used to find exercise effects on CRF; 
• A small number of cancer types. The most of patients had breast or prostate cancer; 
• Some trials didn’t report effect size; 
• Researchers measured fatigue with different self-report scale and for different length; this can’t afford 
us to advise a better way to select a design of research; 
• Patients were undergoing different therapy (chemotherapy, radiotherapy, etc.) or they concluded it 
and we can’t choose the best exercise treatment for every care; 
• In some trial patients did exercises without the supervision of a specialist during the session; this is 
a limitation to quantify accurate data; 
• Some trials reported several outcomes in follow-ups which were done at a different moment. 
 
CONCLUSIONS 
 
Based on this systematic review and the findings of the investigated studies shown in Table 3, we conclude 
that exercise improves CRF, especially with aerobic and combined programs. This systematic review can 
help the exercise professional to plan exercise sessions correctly and we recommend increasing quality and 
quantity of exercise in cancer patients by monitoring every parameter during sessions. Nevertheless, more 
studies are needed to value the effects of physical exercise training on cancer patients and CRF should be 
assessed as a primary outcome. 
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